Price Action Alert: What Will Happen to Exponent, Inc. Next? The Stock Just Reaches 52-Week High

Price Action Alert: What Will Happen to Exponent, Inc. Next? The Stock Just Reaches 52 Week High

The stock of Exponent, Inc. (NASDAQ:EXPO) hit a new 52-week high and has $65.72 target or 6.00% above today’s $62.00 share price. The 6 months bullish chart indicates low risk for the $1.59B company. The 1-year high was reported on Nov, 29 by If the $65.72 price target is reached, the company will be worth $95.40M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 36,010 shares traded hands. Exponent, Inc. (NASDAQ:EXPO) has risen 26.58% since April 26, 2016 and is uptrending. It has outperformed by 21.32% the S&P500.

Analysts await Exponent, Inc. (NASDAQ:EXPO) to report earnings on February, 1. They expect $0.34 earnings per share, down 5.56% or $0.02 from last year’s $0.36 per share. EXPO’s profit will be $8.72M for 45.59 P/E if the $0.34 EPS becomes a reality. After $0.42 actual earnings per share reported by Exponent, Inc. for the previous quarter, Wall Street now forecasts -19.05% negative EPS growth.

According to Zacks Investment Research, “Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors.”

Insitutional Activity: The institutional sentiment decreased to 1.06 in Q2 2016. Its down 0.65, from 1.71 in 2016Q1. The ratio worsened, as 12 funds sold all Exponent, Inc. shares owned while 39 reduced positions. 19 funds bought stakes while 68 increased positions. They now own 23.37 million shares or 1.97% more from 22.92 million shares in 2016Q1.
Teachers Retirement Of The State Of Kentucky holds 0.03% or 41,480 shares in its portfolio. The Florida-based Raymond James Service Advsrs Inc has invested 0.02% in Exponent, Inc. (NASDAQ:EXPO). Granahan Mgmt Ma holds 0.13% of its portfolio in Exponent, Inc. (NASDAQ:EXPO) for 61,144 shares. Jpmorgan Chase And Company accumulated 0% or 289,869 shares. The New York-based Renaissance Tech Limited Liability Company has invested 0.06% in Exponent, Inc. (NASDAQ:EXPO). Nationwide Fund Advsr holds 0.03% or 136,683 shares in its portfolio. Architects holds 0.02% of its portfolio in Exponent, Inc. (NASDAQ:EXPO) for 1,000 shares. 1St Advsrs has invested 0.06% of its portfolio in Exponent, Inc. (NASDAQ:EXPO). Texas Permanent School Fund owns 19,846 shares or 0.02% of their US portfolio. Nordea Invest Mngmt accumulated 11,712 shares or 0% of the stock. Tompkins Fincl last reported 0% of its portfolio in the stock. Pinebridge Investments Lp has invested 0.01% of its portfolio in Exponent, Inc. (NASDAQ:EXPO). Da Davidson And last reported 0.01% of its portfolio in the stock. Gemmer Asset Ltd Liability Corporation last reported 92 shares in the company. Confluence Inv Management Lc last reported 33,594 shares in the company.

Insider Transactions: Since June 3, 2016, the stock had 0 buys, and 14 sales for $3.97 million net activity. JOHNSTON PAUL R had sold 5,500 shares worth $325,993. Kytomaa Harri had sold 5,500 shares worth $340,480 on Monday, November 14. $135,882 worth of Exponent, Inc. (NASDAQ:EXPO) was sold by RIGGINS STEPHEN C on Tuesday, October 25. Murray Steven J also sold $19,501 worth of Exponent, Inc. (NASDAQ:EXPO) on Monday, October 24. 14,557 shares were sold by SCHLENKER RICHARD L JR, worth $829,491 on Tuesday, October 25. Boehm Paul sold $260,910 worth of stock. GAULKE MICHAEL R also sold $238,198 worth of Exponent, Inc. (NASDAQ:EXPO) shares.

Another recent and important Exponent, Inc. (NASDAQ:EXPO) news was published by which published an article titled: “Ex-Dividend Reminder: Waste Management, Herman Miller and Exponent” on November 28, 2016.

EXPO Company Profile

Exponent, Inc. (Exponent), incorporated on May 9, 1989, along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. The Company’s service offerings are provided on a project-by-project basis. It operates over 20 practices and centers in two operating divisions: Engineering and Other Scientific, and Environmental and Health. The Company’s Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, technology development, thermal sciences and vehicle analysis services. The Company’s Environmental and Health segment includes chemical regulation and food safety; ecological and biological sciences; environmental and earth sciences; epidemiology, biostatistics and computational biology; occupational and environmental health risk assessment, and toxicology and mechanistic biology. Exponent serves clients in automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing and technology, among others.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment